New research from NYU Grossman School of Medicine shows that bacterial blooms of the gut bacterium Ruminococcus blautia gnavus occurred at the same time as disease flare-ups.
Lupus Worsened by Autoantibodies
In an effort to understand the origin of systemic lupus erythematosus and why some patients present with more severe disease than others, Johns Hopkins Medicine researchers say they have identified a type of autoantibody that may worsen the condition and have also found how these autoantibodies originate (Anti-DNA antibodies are a hallmark of patients with SLE.).
Study identifies potential new approach for treating lupus
Protein in blood could help to treat lupus
Sleep deprivation tied to lupus risk in women
New molecule shows promise for prevention and treatment of lupus
A new study has found promise in a compound which blocks signals from special receptors in the body thought to be involved in the autoimmune response. More specifically, these receptors are proteins which are designed to detect viral RNA, but mount an autoimmune response when they mistake the body’s own RNA as a threat.
Scientists find a genetic cause of lupus
Hydroxychloroquine might reduce risk of endometriosis in patients with SLE
SLE patients have different skin microorganisms
The skin is the second most affected organ in lupus patients. Cutaneous involvement occurs in approximately 80% of patients with systemic lupus.
Interaction between the host and skin microorganism is a complex process. There are few studies on the diversity of skin microbes in SLE patients. The new study aims to explore the relationship between skin microorganisms and SLE
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in lupus
Hydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine. The aim of this study was to investigate whether hydroxychloroquine increases new-onset arrhythmia among patients with systemic lupus erythematosus.
Mediterranean Diet Benefits Patients With Lupus
smoking exposure predicts cutaneous manifestations and damage in SLE
Higher risk of hearing loss with SLE
For lupus mental Health physical activity matters
Studies Show Similar COVID-19 Risk Factors for Patients with Lupus as General Population
SLE during pregnancy is not associated with school performance in offspring
Potential Drug for Cutaneous Lupus Found Safe and Effective in Phase 2 Trial
New test method can offer safer dosages of hydroxychloroquine
Researchers have developed a new method to measure levels of the anti-malarial drug hydroxychloroquine (HCQ) in patients with lupus.
A disadvantage of hydroxychloroquine is its side effects which can be avoided, however, if the dosage is adjusted for each patient, said the study researchers from Uppsala University in Sweden.
